New England Biotech Headlines Today is December 01, 2009. All times in Eastern Time. 12/01/2009 - 05:54 PM Dyax Announces FDA Approval of KALBITOR® (ecallantide) for the Treatment of Acute Attacks of Hereditary Angioedema in Patients 16 Years of Age and Older 12/01/2009 - 04:30 PM Alexion Appoints William R. Keller to its Board of Directors 12/01/2009 - 12:15 PM Millennium Launches Interactive Website of Award-Winning Cancer Initiative 12/01/2009 - 12:00 PM Picis Extends Market Leadership with New ED PulseCheck Signings 12/01/2009 - 09:30 AM CRi Announces Results of Signaling Pathway Protein Study 12/01/2009 - 09:02 AM Genzyme Begins Shipping Newly Produced Cerezyme from Allston Plant 12/01/2009 - 08:15 AM Acceleron Pharma to Present Data on ACE-011 and ACE-536 at the 51st Annual Meeting of the American Society of Hematology 12/01/2009 - 08:00 AM 70% Of Physicians on Sermo State They Would Increase Their Use of Niacin Based on the ARBITER 6-HALTS Trial 12/01/2009 - 07:30 AM Helicos and Mass General Hospital Publish Epigenomic Study in Nature Methods 12/01/2009 - 07:00 AM FORMA Therapeutics Raises $25.5M Series B Financing 11/30/2009 - 03:19 PM VELCADE® (Bortezomib) for Injection to be Featured in Plenary Session at American Society of Hematology 11/30/2009 - 09:16 AM Leipzig to Play Host to EuroMedtech™ 2010 11/30/2009 - 07:00 AM Three Lou Gehrig’s Disease (ALS) Organizations Grant Funding for Research Collaboration Between RXi Pharmaceuticals and UMass Medical School 11/27/2009 - 10:45 AM Phase Forward to Present at the 21st Annual Piper Jaffray Health Care Conference 11/25/2009 - 08:35 AM Curis to Present at Piper Jaffray 21st Annual Healthcare Conference 1 2   Next »

About Us   |   Contact Us   |   Privacy Statement   |   Terms of Use   |   © Business Wire 2009